Research never stops


Sep 29, 2016

Evotec receives further important pre-clinical milestone in endometriosis alliance with Bayer

Hamburg, Germany, 29 September 2016: Evotec AG announced today that its multi-target endometriosis alliance with Bayer has reached another key pre-clinical milestone for the transition of a project from the alliance portfolio into pre-clinical development.

- read more
Sep 28, 2016

Evotec enters into strategic multi-target alliance with C4X Discovery

Hamburg, Germany, 28 September 2016: Evotec AG today announced a multi-target collaboration with C4X Discovery Holdings plc.

- read more
Sep 22, 2016

Evotec enters into a research collaboration with Inserm in oncology

Hamburg, Germany, 22 September 2016: Evotec AG announced today that the Company has entered into a research collaboration with Inserm Transfert, the private subsidiary of the French National Institute of Health and Medical Research.

- read more
Sep 21, 2016

Evotec and Bayer partner to develop new treatments to fight kidney diseases

Hamburg, Germany, 21 September 2016: Evotec AG today announced that Evotec and Bayer have entered into a five-year, multi-target research partnership.


- read more
Aug 10, 2016

Evotec AG reports results of first half of 2016

Hamburg, Germany, 10 August 2016: Evotec AG today reported financial results and corporate updates for the first half of 2016.

- read more
Aug 04, 2016

Evotec achieves clinical development milestone as part of its multi-target alliance with Bayer in endometriosis

Hamburg, Germany, 04 August 2016: Evotec AG announced today that it has reached a milestone from Bayer for the progression of a programme from the alliance portfolio into Phase I clinical development for the treatment of endometriosis, triggering a milestone payment to Evotec.

- read more
Jul 19, 2016

Evotec AG increases its profitability guidance for 2016

Hamburg, Germany, 19 July 2016: Evotec AG today announced that, in the context of the half year results published on 10 August 2016, it increases its financial guidance for the current year.

- read more
Jul 11, 2016

Evotec awarded contract from Antibiotic Research UK to begin integrated drug discovery collaboration

Jul 06, 2016

Evotec enters license agreement for access to CRISPR-Cas9 gene editing technology

Jun 29, 2016

Evotec and Ellersbrook join forces to accelerate TargetNASH

Jun 14, 2016

Resolutions of the Annual General Meeting of Evotec AG

Jun 10, 2016

Evotec receives European Mediscience Award for ‘Best Communication’

May 24, 2016

Evotec extends integrated drug discovery alliance with Genentech

May 10, 2016

Evotec AG reports results of first quarter 2016

Apr 26, 2016

Evotec and ex scientia announce partnership to discover bispecific small molecule immuno-oncology therapeutics

Apr 19, 2016

Evotec and Pierre Fabre sign multi-year compound management agreement

Mar 22, 2016

Evotec FY 2015: Excellent execution meets first-in-class innovation

Mar 22, 2016

Evotec spins off auto-immune disease company as 'Topas Therapeutics GmbH'

Mar 10, 2016

Evotec achieves milestone in collaboration with Padlock Therapeutics

Feb 02, 2016

Evotec awarded grant from The Michael J. Fox Foundation for Parkinson's Research

Jan 12, 2016

Evotec achieves important milestone in TargetAD collaboration with Janssen in Alzheimer's disease

Jan 07, 2016

Evotec and UCB sign multi-year sample management agreement

Watch a short video clip on this press release

- read more